Percutaneous endoscopic gastrostomy (PEG‐tube) placement is a relatively safe procedure for enteral nutrition in appropriately selected patients. Gastroenterologists are sought for PEG‐tube placements in COVID‐19 patients with vent‐dependent respiratory failure. Although PEG‐tube placement along with tracheostomy may expedite discharge planning, there are unique challenges for endoscopy staff because of the potential for viral transmission. 1 There is no gastroenterological society recommendation for a maximum duration of nasogastric (NG) or oro‐gastric (OG) tube in critically ill patients. However, the general consensus is to wait about 4 weeks because of increased risk of complications beyond this duration. 2
If a PEG‐tube is deemed necessary, a multidisciplinary discussion (patient’s family, primary, procedural, and palliative care teams) should be held to discuss risks and benefits of the procedure, nutrition goals, and overall prognosis (Table 1). Guidelines from the COVID‐19 tracheostomy task force recommend waiting for at least 21 days before performing a tracheostomy. 3 A similar window period of 3–4 weeks for PEG‐tube placement can be considered to avoid transmission. Patients’ transport should be minimized to reduce the transmission risk; however, barrier methods (plastic patient‐isolation drapes) should be used if deemed necessary. A small size hole (about 6 inches) can be made in the drape to access expected site of PEG‐tube placement. All patients should receive prophylactic antibiotics as per guidelines. The “pull‐technique” should be used while minimizing suctioning in addition to practicing “cluster care” 4 while performing other procedures/imaging needed for the patient (PEG‐tube placement immediately before or after tracheostomy to minimize transport and exposure risk) (Table 2). In short, devising institutional guidelines regarding appropriate patient selection, optimizing the timing of PEG‐tube placement along with tracheostomy if needed, while observing a multidisciplinary team approach, and minimizing endoscopic personnel during the procedure can decrease the exposure risk and improve patient care as well as free‐up intensive care unit (ICU) resources.
Table 1.
Advantages | Disadvantages |
---|---|
|
|
Advantages, disadvantages of PEG tube placement. Percutaneous gastrostomy (PEG) tube placement, coronavirus disease 2019 (COVID‐19).
Table 2.
Factors | Comments |
---|---|
Appropriate selection |
|
Indications |
|
Contraindications |
|
Multidisciplinary approach |
|
Decrease movement |
|
Cluster method |
|
Procedure specifics |
|
Percutaneous gastrostomy (PEG) tube placement. COVID‐19, coronavirus disease 2019; NJ, Nasogastric; OG, Orogastric; PPE, personal protective equipment.
Authors declare no conflicts of interest for this article.
References
- 1. Perisetti A, Gajendran M, Boregowda U et al. COVID‐19 and gastrointestinal endoscopies: Current insights and emergent strategies. Dig Endosc 2020; 32: 715–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Wang J, Liu M, Liu C et al. Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for patients with head and neck cancer: A systematic review. J Radiat Res 2014; 55: 559–67. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. McGrath BA, Brenner MJ, Warrillow SJ et al. Tracheostomy in the COVID‐19 era: Global and multidisciplinary guidance. Lancet Respir Med 2020; 8: 717–25. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Micic D, Wall E, Semrad C. Nutrition support in the ICU—a refresher in the era of COVID‐19. Am J Gastroenterol 2020; 115: 1367–70. [DOI] [PMC free article] [PubMed] [Google Scholar]